138 related articles for article (PubMed ID: 17889534)
1. Benzazepinone Nav1.7 blockers: potential treatments for neuropathic pain.
Hoyt SB; London C; Ok H; Gonzalez E; Duffy JL; Abbadie C; Dean B; Felix JP; Garcia ML; Jochnowitz N; Karanam BV; Li X; Lyons KA; McGowan E; Macintyre DE; Martin WJ; Priest BT; Smith MM; Tschirret-Guth R; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
Bioorg Med Chem Lett; 2007 Nov; 17(22):6172-7. PubMed ID: 17889534
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.
Hoyt SB; London C; Gorin D; Wyvratt MJ; Fisher MH; Abbadie C; Felix JP; Garcia ML; Li X; Lyons KA; McGowan E; MacIntyre DE; Martin WJ; Priest BT; Ritter A; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
Bioorg Med Chem Lett; 2007 Aug; 17(16):4630-4. PubMed ID: 17588748
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel class of biphenyl pyrazole sodium channel blockers for treatment of neuropathic pain.
Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Eid R; Fisher MH; Parsons WH; Wyvratt MJ; Lyons KA; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Weber A; Duffy JL
Bioorg Med Chem Lett; 2010 Dec; 20(24):7479-82. PubMed ID: 21106456
[TBL] [Abstract][Full Text] [Related]
4. Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain.
Scanio MJ; Shi L; Drizin I; Gregg RJ; Atkinson RN; Thomas JB; Johnson MS; Chapman ML; Liu D; Krambis MJ; Liu Y; Shieh CC; Zhang X; Simler GH; Joshi S; Honore P; Marsh KC; Knox A; Werness S; Antonio B; Krafte DS; Jarvis MF; Faltynek CR; Marron BE; Kort ME
Bioorg Med Chem; 2010 Nov; 18(22):7816-25. PubMed ID: 20965738
[TBL] [Abstract][Full Text] [Related]
5. Substituted biaryl pyrazoles as sodium channel blockers.
Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Fisher MH; Wyvratt MJ; Lyons K; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Parsons WH
Bioorg Med Chem Lett; 2010 Sep; 20(18):5480-3. PubMed ID: 20709545
[TBL] [Abstract][Full Text] [Related]
6. A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain.
Hoyt SB; London C; Abbadie C; Felix JP; Garcia ML; Jochnowitz N; Karanam BV; Li X; Lyons KA; McGowan E; Priest BT; Smith MM; Warren VA; Thomas-Fowlkes BS; Kaczorowski GJ; Duffy JL
Bioorg Med Chem Lett; 2013 Jun; 23(12):3640-5. PubMed ID: 23652221
[TBL] [Abstract][Full Text] [Related]
7. 3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activity.
Hoyt SB; London C; Wyvratt MJ; Fisher MH; Cashen DE; Felix JP; Garcia ML; Li X; Lyons KA; Euan MacIntyre D; Martin WJ; Priest BT; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
Bioorg Med Chem Lett; 2008 Mar; 18(6):1963-6. PubMed ID: 18289851
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME
Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613
[TBL] [Abstract][Full Text] [Related]
9. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
[TBL] [Abstract][Full Text] [Related]
10. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
11. Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in rats.
Brochu RM; Dick IE; Tarpley JW; McGowan E; Gunner D; Herrington J; Shao PP; Ok D; Li C; Parsons WH; Stump GL; Regan CP; Lynch JJ; Lyons KA; McManus OB; Clark S; Ali Z; Kaczorowski GJ; Martin WJ; Priest BT
Mol Pharmacol; 2006 Mar; 69(3):823-32. PubMed ID: 16301337
[TBL] [Abstract][Full Text] [Related]
12. Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers.
Tyagarajan S; Chakravarty PK; Zhou B; Fisher MH; Wyvratt MJ; Lyons K; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Parsons WH
Bioorg Med Chem Lett; 2010 Sep; 20(18):5536-40. PubMed ID: 20709552
[TBL] [Abstract][Full Text] [Related]
13. Imidazopyridines: a novel class of hNav1.7 channel blockers.
London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
[TBL] [Abstract][Full Text] [Related]
14. Sodium channel blockers for neuropathic pain.
Zuliani V; Rivara M; Fantini M; Costantino G
Expert Opin Ther Pat; 2010 Jun; 20(6):755-79. PubMed ID: 20384535
[TBL] [Abstract][Full Text] [Related]
15. 2,4(5)-Diarylimidazoles: synthesis and biological evaluation of a new class of sodium channel blockers against hNa(v)1.2.
Rivara M; Baheti AR; Fantini M; Cocconcelli G; Ghiron C; Kalmar CL; Singh N; Merrick EC; Patel MK; Zuliani V
Bioorg Med Chem Lett; 2008 Oct; 18(20):5460-2. PubMed ID: 18818069
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.
Ok D; Li C; Abbadie C; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Martin WJ; Priest BT; Smith MM; Williams BS; Wyvratt MJ; Parsons WH
Bioorg Med Chem Lett; 2006 Mar; 16(5):1358-61. PubMed ID: 16337121
[TBL] [Abstract][Full Text] [Related]
17. Voltage-gated sodium channel blockers for the treatment of neuropathic pain.
Cummins TR; Rush AM
Expert Rev Neurother; 2007 Nov; 7(11):1597-612. PubMed ID: 17997706
[TBL] [Abstract][Full Text] [Related]
18. Future potential and status of selective sodium channel blockers for the treatment of pain.
Priest BT
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in the structure-activity relationship study of small-molecule sodium channel blockers with analgesic effects].
Li W; Zhou Y; Liu HM; You QD
Yao Xue Xue Bao; 2009 Feb; 44(2):101-8. PubMed ID: 19408676
[TBL] [Abstract][Full Text] [Related]
20. Novel sodium channel antagonists in the treatment of neuropathic pain.
Rivara M; Zuliani V
Expert Opin Investig Drugs; 2016; 25(2):215-26. PubMed ID: 26576738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
